Home › Stocks › GYRE › All Fund Holders
GYRE — GYRE THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 22 · Reported value held: $23.56M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.20M | $8.48M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 993.94K | $6.55M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 532.95K | $3.51M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 184.29K | $1.21M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 169.54K | $1.12M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 86.23K | $568.29K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 62.75K | $413.52K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 41.69K | $274.74K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2024 | 13.98K | $244.35K | 0.00% | New |
| Renaissance Technologies history | Q2 2024 | 13.90K | $165.83K | 0.00% | New |
| Marshall Wace history | Q2 2024 | 10.72K | $127.89K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 18.76K | $123.65K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 18.49K | $121.84K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 17.94K | $118.22K | 0.00% | Add |
| Lazard Asset Management history | Q3 2025 | 14.93K | $111.39K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 16.30K | $107.40K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 14.97K | $98.68K | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 12.53K | $82.54K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 8.59K | $56.58K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 7.83K | $50.51K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 2.05K | $13.54K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 15.03K | $100 | 0.00% | New |